艾美捷Detroit R&D特色15-HETE高血壓/癌癥ELISA試劑盒
艾美捷Detroit R&D?15-HETE高血壓/癌癥ELISA試劑盒#15H1用于測(cè)定生物中15-HETE(15-羥基二十碳四烯酸)的水平樣品。使用真實(shí)的15-HETE和脂肪酸研究15-HETE ELISA的特異性可以預(yù)期在其結(jié)構(gòu)上與15-HETE競(jìng)爭(zhēng)與針對(duì)15-HETE的抗體的結(jié)合???15-HETE不與12-HETE或20-HETE發(fā)生交叉反應(yīng)。
?
15-HETE由花生四烯酸(AA)通過(guò)15-脂氧合酶(LOX)活性形成(1)。已經(jīng)表明-HETE參與多種病理狀況,包括癌癥(2)、高血壓(3)、過(guò)敏性鼻炎(4)和關(guān)節(jié)炎(5)。有趣的是,15-LOX還產(chǎn)生脂毒素A4和B4。也可以使用這種15(S)-HETE ELISA用于15-LOX活性的測(cè)量。
?
這種競(jìng)爭(zhēng)性ELISA可用于多達(dá)24個(gè)樣品的一式三份分析,并包含一個(gè)96孔板,一個(gè)小瓶15-HETE標(biāo)準(zhǔn)品、一小瓶15-HETE-綴合的HRP以及用于樣品和HRP稀釋液的緩沖液,以及洗盤(pán)子。
?

Detroit R&D?15-HETE高血壓/癌癥ELISA試劑盒相關(guān)研究:?
12-HETE 高血壓酶聯(lián)免疫功能試劑盒
?
Detroit R&D15-HETE高血壓/癌癥ELISA試劑盒引用文獻(xiàn):
1. Dobrian AD, Lieb DC, Cole BK, Taylor-Fishwick DA,Chakrabarti SK, Nadler JL. Functional and pathological roles of the 12- and 15-lipoxygenases. Progress in Lipid Research (2011) 50, 115-131 and references therein.
2. Pidgeon GP, Lysaght J, Krishnamoorthy S, Reynolds JV,O'Byrne K, Nie D, Honn KV. Lipoxygenase metabolism:roles in tumor progression and survival. Cancer Metastasis Rev (2007) 26, 503–524 and references therein.
3. M.D. Mitchell and J.M. Koenig. ?Increased production of 15-hydroxyeicosatetraenoic acid by placentae from pregnancies complicated by pregnancy-induced hypertension
4. Ramis I, Catafau JR, Serra J, Bulbena O, Picado C, Gelpi E. In vivo release of 15-HETE and other arachidonic acid metabolites in nasal secretions during early allergic reactions. Prostaglandins (1991) 42(5):411-20
5. Fogh, K., et. al. 15-Hydroxy-eicosatetraenoic acid (15-Hete) inhibits carragheenan-induced experimental arthritis and reduces synovial fluid leukotriene B4 (LTB4). (1989) Prostaglandins 37: 213-228
?
Detroit R&D專(zhuān)注于心血管疾病、癌癥的研究,診斷和治療領(lǐng)域。涉及環(huán)境健康科學(xué)、高血壓、乳腺癌和前列腺癌相關(guān)研究領(lǐng)域。艾美捷科技是Detroit R&D的中國(guó)代理商,為科研工作者提供優(yōu)質(zhì)的產(chǎn)品與服務(wù)。